Use of nicotinamide and pyridoxal-5-phosphate in the treatment of experimental epilepsy.
Kryzhanovskii
G N
GN
Shandra
A A
AA
D000818:Animals; D000927:Anticonvulsants; D002415:Cats; D004827:Epilepsy / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D009536:Niacinamide / Q000627:therapeutic use*; D010406:Penicillins / Q000037:antagonists & inhibitors; D011732:Pyridoxal Phosphate / Q000627:therapeutic use*; D013331:Strychnine / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000927:Anticonvulsants; D010406:Penicillins; D009536:Niacinamide; D005680:gamma-Aminobutyric Acid; D011732:Pyridoxal Phosphate; D013331:Strychnine